Yi Shi, Dong Zhan, Xin Sun. A comprehensive pan-cancer multi-omics analysis identifies CDKN2A as a promising biomarker associated with clinical outcomes and immune infiltration. // Cytokine. – DOI: 10.1016/j.cyto.2026.157228. – URL: https://www.sciencedirect.com/science/article/pii/S1043466626001237?dgcid=rss_sd_all
Yi Shi, Dong Zhan, & Xin Sun A comprehensive pan-cancer multi-omics analysis identifies CDKN2A as a promising biomarker associated with clinical outcomes and immune infiltration. Cytokine. https://doi.org/10.1016/j.cyto.2026.157228
Yi Shi, et al. “A comprehensive pan-cancer multi-omics analysis identifies CDKN2A as a promising biomarker associated with clinical outcomes and immune infiltration.” Cytokine. doi:10.1016/j.cyto.2026.157228.
@article{Shi,
title = {A comprehensive pan-cancer multi-omics analysis identifies CDKN2A as a promising biomarker associated with clinical outcomes and immune infiltration},
author = {Shi, Yi and Zhan, Dong and Sun, Xin},
journal = {Cytokine},
doi = {10.1016/j.cyto.2026.157228},
url = {https://www.sciencedirect.com/science/article/pii/S1043466626001237?dgcid=rss_sd_all}
}